Low molecular weight heparin attenuates multiple organ failure in a murine model of disseminated intravascular coagulation
- PMID: 15942357
- DOI: 10.1097/01.ccm.0000166370.94927.b6
Low molecular weight heparin attenuates multiple organ failure in a murine model of disseminated intravascular coagulation
Abstract
Objective: Bacterial sepsis causes widespread vascular inflammation that frequently leads to disseminated intravascular coagulation (DIC). Although intravascular coagulation contributes to organ failure, it is often debated whether anticoagulant therapy produces any beneficial effects in patients with DIC. The aim of this study was to document potential beneficial effects of low molecular weight heparin (LMWH) in a lipopolysaccharide-induced DIC model.
Design: Controlled animal experiment combined with an in vitro laboratory study.
Setting: Academic research laboratory.
Subjects: C57BL/6 mice subjected to two injections of Serratia Marcescens lipopolysaccharide (LPS) resulting in the generalized Shwartzman's reaction as a model for DIC.
Interventions: LMWH (5 IU of anti-Xa activity) or saline was administered before both LPS injections and 10 hrs after the first exposure to LPS. To test the effect of LMWH on LPS-driven monocyte inflammatory responses, a human monocyte-human umbilical vein endothelial cell co-culture was used to determine E-selectin expression as a marker of monocyte adherence.
Measurements and main results: In our murine DIC model, LMWH had no effect on markers of inflammation. In addition, no effect of LMWH was detected on monocyte adherence in the human monocyte-human umbilical vein endothelial cell co-culture. Organ damage, contrarily, was significantly reduced as determined by hepatic necrosis (p < .05), lung epithelial protein leakage (p < .05), and creatinine release from kidneys into plasma (p < .01). LMWH protection from organ failure resulted in an increase in survival (p = .06) in this model for DIC.
Conclusions: These results demonstrate the significance of blood coagulation in the progression of DIC and hint at a beneficial role for LMWH anticoagulation in the management of DIC.
Comment in
-
Heparins in sepsis-induced disseminated intravascular coagulation: low weight-high impact?Crit Care Med. 2005 Jun;33(6):1455-7. doi: 10.1097/01.ccm.0000166703.33220.2d. Crit Care Med. 2005. PMID: 15942389 No abstract available.
Similar articles
-
Expert consensus for the treatment of disseminated intravascular coagulation in Japan.Thromb Res. 2010 Jan;125(1):6-11. doi: 10.1016/j.thromres.2009.08.017. Epub 2009 Sep 25. Thromb Res. 2010. PMID: 19782389 Review.
-
Beneficial effect of low-molecular-weight heparin against lipopolysaccharide-induced disseminated intravascular coagulation in rats is abolished by coadministration of tranexamic acid.Intensive Care Med. 2004 Oct;30(10):1950-5. doi: 10.1007/s00134-004-2349-7. Epub 2004 Jun 15. Intensive Care Med. 2004. PMID: 15480547
-
Significance of decreased plasma D-dimer levels following lipopolysaccharide-induced disseminated intravascular coagulation in rats.Int J Hematol. 2004 May;79(4):394-9. doi: 10.1532/ijh97.03168. Int J Hematol. 2004. PMID: 15218973
-
Microvascular coagulopathy and disseminated intravascular coagulation.Crit Care Med. 2001 Jul;29(7 Suppl):S95-7; discussion S97-8. doi: 10.1097/00003246-200107001-00030. Crit Care Med. 2001. PMID: 11445741 Review.
-
Urinary protein C inhibitor as a therapeutic agent to disseminated intravascular coagulation (DIC): a comparison with low molecular weight heparin in rats with lipopolysaccharide-induced DIC.Biol Pharm Bull. 2000 Sep;23(9):1046-50. doi: 10.1248/bpb.23.1046. Biol Pharm Bull. 2000. PMID: 10993202
Cited by
-
TRPC channels blockade abolishes endotoxemic cardiac dysfunction by hampering intracellular inflammation and Ca2+ leakage.Nat Commun. 2022 Dec 2;13(1):7455. doi: 10.1038/s41467-022-35242-0. Nat Commun. 2022. PMID: 36460692 Free PMC article.
-
Effect of anticoagulant and platelet inhibition on the risk of bacteremia among patients with acute pyelonephritis: a retrospective cohort study.BMC Infect Dis. 2022 May 31;22(1):509. doi: 10.1186/s12879-022-07474-4. BMC Infect Dis. 2022. PMID: 35641940 Free PMC article.
-
Using heparin molecules to manage COVID-2019.Res Pract Thromb Haemost. 2020 Jun 9;4(4):518-523. doi: 10.1002/rth2.12353. eCollection 2020 May. Res Pract Thromb Haemost. 2020. PMID: 32542212 Free PMC article. Review.
-
Genistein has the function of alleviating and treating disseminated intravascular coagulation caused by lipopolysaccharide.J Nat Med. 2018 Sep;72(4):846-856. doi: 10.1007/s11418-018-1215-9. Epub 2018 May 14. J Nat Med. 2018. PMID: 29761425
-
Near-Infrared Emitting PbS Quantum Dots for in Vivo Fluorescence Imaging of the Thrombotic State in Septic Mouse Brain.Molecules. 2016 Aug 18;21(8):1080. doi: 10.3390/molecules21081080. Molecules. 2016. PMID: 27548125 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical